Post-earnings recap
Reported
Tue, May 9, 2017
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
ACADIA Pharmaceuticals reported a loss per share of $0.72, which was below expectations. Despite this miss, the stock rose by 1.48%, indicating that investors may have had lower expectations or reacted positively to other aspects of the company's performance not detailed in the earnings report.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.72 | N/A | -0.63% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.